These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14622555)

  • 1. [Coronary risk in Spain and its treatment with lipid-lowering drugs].
    Maiques Galán A; Villar Alvarez F; Llor Vila C; Torcal Laguna J
    Aten Primaria; 2003 Oct; 32(7):420-2. PubMed ID: 14622555
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid-lowering drug therapy: more knowledge leads to more problems for composers of guidelines.
    Durrington PN; Illingworth DR
    Curr Opin Lipidol; 2000 Aug; 11(4):345-9. PubMed ID: 10945714
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract]   [Full Text] [Related]  

  • 4. Trials of lipid-lowering therapy in primary prevention of coronary heart disease.
    Jones PH
    Curr Opin Lipidol; 1995 Dec; 6(6):365-8. PubMed ID: 8750249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
    Davidson MH
    Curr Atheroscler Rep; 2003 Sep; 5(5):418-22. PubMed ID: 12911853
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary and secondary prevention using lipid-lowering therapies.
    Holm K
    J Cardiovasc Nurs; 2000 Jan; 14(2):1-8. PubMed ID: 10653271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid lowering in high-risk populations: how low should we go?
    Watson K
    Ethn Dis; 2001; 11(4):834-7. PubMed ID: 11763308
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency of lipid-lowering therapy after a coronary event in Helsinki, Finland.
    Strandberg TE; Vanhanen H; Tikkanen MJ
    Am J Cardiol; 1999 Jul; 84(1):95, A8. PubMed ID: 10404860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention of coronary heart disease: where do we go from here?
    Gotto AM
    Arch Intern Med; 2001 Apr; 161(7):922-4. PubMed ID: 11295953
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ischemic heart diseases and lipid metabolism: a circulation specialist's viewpoint].
    Umemoto S; Matsuzaki M
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):2093-9. PubMed ID: 11769507
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hyperlipidaemia as a risk factor for coronary heart disease: the role of fibrates.
    Linssen R
    Hosp Med; 1999 Apr; 60(4):298-301. PubMed ID: 10396439
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid disorders in NIDDM: implications for treatment.
    Taskinen MR; Smith U
    J Intern Med; 1998 Nov; 244(5):361-70. PubMed ID: 9845851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case for lipid-lowering?
    Durrington P
    Diabet Med; 2000 Sep; 17 Suppl 2():4-5. PubMed ID: 11048824
    [No Abstract]   [Full Text] [Related]  

  • 14. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of coronary heart disease by therapy of hyperlipidemia. Between cholesterol hysteria and therapeutic realism].
    Deller M; Huth K
    Fortschr Med; 1992 Sep; 110(25):463-6. PubMed ID: 1398397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of 4S evidence on baseline lipid levels.
    Jacobson TA
    Lancet; 1995 Jul; 346(8968):181-2. PubMed ID: 7603245
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating lipid disorders.
    Manninen V; Mälkönen M; Tuomilehto J
    Am Heart J; 1979 May; 97(5):674-6. PubMed ID: 219673
    [No Abstract]   [Full Text] [Related]  

  • 18. Ineffectiveness of lipid-lowering therapy in primary care.
    Van Ganse E; Souchet T; Laforest L; Moulin P; Bertrand M; Le Jeunne P; Travier N; Yin D; Alemao E; de Pouvourville G
    Br J Clin Pharmacol; 2005 Apr; 59(4):456-63. PubMed ID: 15801941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Currently available lipid-lowering agents.
    Levy RI
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical drug therapy for common hyperlipidaemias.
    Tikkanen MJ
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):719-42. PubMed ID: 2082904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.